Medicare Enrolled
Dr. Frank King, MD
Physical Medicine & Rehabilitation · Mission Viejo, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. King from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. King?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. King
Dr. Frank King is a physical medicine & rehabilitation specialist in Mission Viejo, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. King performed 17,093 Medicare services across 1,480 unique beneficiaries.
Between the years covered by Open Payments, Dr. King received a total of $12,554 from 62 pharmaceutical and/or device companies across 678 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physical medicine & rehabilitation. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. King is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in CA
$12,554 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,093
Medicare services
Top 2% in CA for physical medicine & rehabilitation
1,480
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~900 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection (Xeomin), per unit An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit. |
5,800 | $4 | $15 |
| Bupivacaine injection, 0.5 mg An injection of bupivacaine, a local anesthetic, administered in a dose of 0.5 mg. |
5,104 | $0 | $1 |
| Injection, ropivacaine hydrochloride, 1 mg | 2,806 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
933 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
808 | $103 | $304 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
450 | $71 | $215 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
190 | $1 | $5 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
119 | $51 | $345 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
87 | $139 | $408 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
81 | $100 | $285 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
70 | $1 | $5 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
65 | $78 | $200 |
| Spinal drug pump reprogramming and refill A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir. |
55 | $81 | $293 |
| Electronic analysis and reprogramming of spinal drug pump This procedure involves electronically analyzing and reprogramming a spinal canal drug infusion pump. It does not include the surgical insertion or removal of the device. |
50 | $35 | $141 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
50 | $49 | $125 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
47 | $0 | $1 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
41 | $46 | $141 |
| 5% dextrose/water (500 ml = 1 unit) | 39 | $1 | $5 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
30 | $247 | $793 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
30 | $137 | $468 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
29 | $193 | $1,377 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
24 | $106 | $324 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
24 | $171 | $913 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
22 | $61 | $706 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
21 | $209 | $605 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
19 | $105 | $286 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
19 | $64 | $582 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
15 | $206 | $662 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
15 | $105 | $319 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 14 | $67 | $244 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
13 | $54 | $152 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $45 | $137 |
| Destruction of peripheral nerve or branch | 11 | $212 | $370 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
89.3% medium
10.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,554
Total received (2018-2024)
Avg $1,793/year across 7 years
Top 5% in CA for physical medicine & rehabilitation
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
678
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,554 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,816
2023
$2,729
2022
$1,210
2021
$1,242
2020
$1,101
2019
$1,666
2018
$1,790
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$640
ABBVIE INC.
$510
Medtronic, Inc.
$499
Curonix LLC
$313
Collegium Pharmaceutical, Inc.
$155
TerSera Therapeutics LLC
$142
Merz Pharmaceuticals, LLC
$76
Valinor Pharma, LLC
$64
Abbott Laboratories
$53
Nevro Corp.
$51
SCILEX PHARMACEUTICALS INC.
$36
PFIZER INC.
$35
SI-BONE, INC.
$34
Nalu Medical, Inc.
$32
Stryker Corporation
$30
Lundbeck LLC
$28
Ipsen Biopharmaceuticals, Inc
$27
Azurity Pharmaceuticals, Inc.
$24
DePuy Synthes Sales Inc.
$24
Vertos Medical, Inc.
$22
BIOTISSUE HOLDINGS INC.
$22
Top 3 companies account for 58.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,632
Boston Scientific Corporation
$1,081
Medtronic, Inc.
$995
Abbott Laboratories
$879
Curonix LLC
$702
Nevro Corp.
$639
Medtronic USA, Inc.
$607
Collegium Pharmaceutical, Inc.
$579
TerSera Therapeutics LLC
$371
Almatica Pharma LLC
$333
Merz Pharmaceuticals, LLC
$266
BOSTON SCIENTIFIC CORPORATION
$236
Allergan Inc.
$235
Daiichi Sankyo Inc.
$222
Allergan, Inc.
$196
Relievant Medsystems, Inc.
$190
Valinor Pharma, LLC
$180
AbbVie Inc.
$169
ARBOR PHARMACEUTICALS, INC.
$165
Stimwave Technologies Incorporated
$165
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$162
BioDelivery Sciences International, Inc.
$157
SPR Therapeutics, Inc
$149
Merz North America, Inc.
$145
Scilex Pharmaceuticals Inc.
$130
Egalet US Inc
$119
Indivior Inc.
$118
INSYS Therapeutics Inc
$114
PFIZER INC.
$112
DePuy Synthes Sales Inc.
$105
Biohaven Pharmaceutical Holding Company Ltd.
$105
SCILEX PHARMACEUTICALS INC.
$90
Biohaven Pharmaceuticals, Inc.
$84
Novartis Pharmaceuticals Corporation
$84
Jazz Pharmaceuticals Inc.
$81
Vertos Medical, Inc.
$69
Azurity Pharmaceuticals, Inc.
$68
Sentynl Therapeutics, Inc.
$66
West Therapeutics Development, LLC
$64
Lilly USA, LLC
$64
SI-BONE, INC.
$53
Zyla Life Sciences
$52
AstraZeneca Pharmaceuticals LP
$47
Horizon Therapeutics plc
$45
Assertio Therapeutics, Inc.
$38
US WorldMeds, LLC
$36
Horizon Pharma plc
$35
Nalu Medical, Inc.
$32
Iroko Pharmaceuticals, LLC
$30
Stryker Corporation
$30
Lundbeck LLC
$28
Ipsen Biopharmaceuticals, Inc
$27
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$24
BIOTISSUE HOLDINGS INC.
$22
IMPEL PHARMACEUTICALS INC.
$21
ASSERTIO THERAPEUTICS, INC.
$20
RedHill Biopharma Inc.
$16
ASSERTIO THERAPEUTICS, Inc.
$15
CooperSurgical, Inc.
$15
IBSA Pharma Inc.
$14
Arbor Pharmaceuticals, Inc.
$13
Purdue Pharma L.P.
$11
Top 3 companies account for 29.5% of all-time payments
Associated products mentioned in payments ›
ACCUGUIDE · AIMOVIG · Accurian · BELBUCA · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Belbuca · CFNS StimQ Peripheral Nerve StimulatorSystem · COMIRNATY · DUEXIS · Dysport · EMGALITY · Edarbi · Endosee · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · Gralise · HORIZANT · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LEVORPHANOL TARTRATE · LICART · LUCEMYRA · Levorphanol · Levorphanol Tartrate · Lucemyra/Lofexidine · MILD DEVICE KIT · MONOVISC · MOVANTIK · Morphabond ER · Movantik · N'VISION · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Omnia · PAXLOVID · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Protege Family of SCS IPGs · QULIPTA · RELISTOR · RELISTOR ORAL · RESTORE · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUBSYS · SYMPROIC · SYNDROS · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · Subsys · Superion · Trudhesa · UBRELVY · VECTRIS · VIMOVO · VIVLODEX · VYEPTI · Vanta · WaveWriter Alpha Prime 16 · XEOMIN · XTAMPZA · Xeomin · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for physical medicine & rehabilitation in CA.
Geographic Context
Physical medicine & rehabilitations within 10 mi
144
Per 100K population
4.6
County median income
$113,702
Nearest hospital
PROVIDENCE MISSION HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. King is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 5% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. King experienced with botox injection (xeomin), per unit?
Based on Medicare claims data, Dr. King performed 5,800 botox injection (xeomin), per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. King receive payments from pharmaceutical companies?
Yes. Dr. King received a total of $12,554 from 62 companies across 678 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. King's costs compare to other physical medicine & rehabilitations in Mission Viejo?
Dr. King's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. King) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Physical Medicine & Rehabilitation
Common procedures, typical costs, and what industry payments mean in physical medicine & rehabilitation.
Same specialty & city
Physical Medicine & Rehabilitations in Mission Viejo
Browse physical medicine & rehabilitations in Mission Viejo ranked by procedure volume and transparency data.
Highest volume
Top Physical Medicine & Rehabilitations in CA
Physical medicine & rehabilitations ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Physical Medicine & Rehabilitations in CA
Which CA physical medicine & rehabilitations receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology